Results 21 to 30 of about 371,827 (350)

CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features

Haematologica, 2013
Peripheral T-cell lymphoma, not otherwise specified is a heterogeneous group of aggressive neoplasms with indistinct borders. By gene expression profiling we previously reported unsupervised clusters of peripheral T-cell lymphomas, not otherwise ...
Bettina Bisig, Aurélien de Reyniès, Christophe Bonnet, Pierre Sujobert, David S. Rickman, Teresa Marafioti, Georges Delsol, Laurence Lamant, Philippe Gaulard, Laurence de Leval   +9 more
doaj   +1 more source

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.

Blood Advances, 2020
Histone deacetylase inhibitors (HDACi) are active agents for peripheral T-cell lymphoma (PTCL). Anecdotally angioimmunoblastic T-cell lymphoma (AITL) appears to respond better than PTCL-not otherwise specified (NOS) to HDACi.
P. Ghione, Promie Faruque, N. Mehta-Shah, V. Seshan, N. Ozkaya, Shakthi T. Bhaskar, J. Yeung, Michael A. Spinner, M. Lunning, G. Inghirami, A. Moskowitz, N. Galasso, N. Ganesan, C. van der Weyden, J. Ruan, H. Prince, J. Trotman, R. Advani, A. Dogan, S. Horwitz   +19 more
semanticscholar   +1 more source

Peripheral T-Cell Lymphomas [PDF]

Egyptian Journal of Hematology and Bone Marrow Transplantation, 2016
Nodal peripheral T cell lymphomas (TCL) are rare entities with poor prognosis including ALK+ and ALK- systemic anaplastic T-cell lymphoma (ALCL), angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma – not otherwise specified. The role of PET in TCL is less well established compared to other lymphoma entities.
Maria K. Angelopoulou, Fani J. Vlachou, Dimitrios T. Kechagias   +2 more
openaire   +2 more sources

Peripheral T-Cell Lymphoma not otherwise specified with oral manifestation: A Case Report.

Journal of Oral Research, 2020
Peripheral T-Cell Lymphoma Not Otherwise Specified it is a rare type of Non-Hodgkin t-cells malignant tumor whose oral manifestations are difficult to diagnose.
Alvaro Vigouroux, Felipe Lillo, Francisca Donoso   +2 more
doaj   +1 more source

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China

Journal of Hematology & Oncology, 2017
The efficacy and safety of chidamide, a new subtype-selective histone deacetylase (HDAC) inhibitor, have been demonstrated in a pivotal phase II clinical trial, and chidamide has been approved by the China Food and Drug Administration (CFDA) as a ...
Yuankai Shi, B. Jia, W. Xu, Wenyu Li, Ting Liu, Peng Liu, Weili Zhao, Huilai Zhang, Xiuhua Sun, Haiyan Yang, Xi Zhang, Jie Jin, Zhengming Jin, Zhiming Li, L. Qiu, M. Dong, Xiao-bing Huang, Yi Luo, Xiaodong Wang, Xin Wang, Jianqiu Wu, Jingyan Xu, Pingyong Yi, Jianfeng Zhou, Hong-tao He, Lin Liu, Jianzhen Shen, Xiaoqiong Tang, Jinghua Wang, Jianmin Yang, Q. Zeng, Zhihui Zhang, Z. Cai, Xiequn Chen, K. Ding, M. Hou, Huiqiang Huang, Xiaoling Li, R. Liang, Qi-fa Liu, Yuqin Song, H. Su, Yu-huan Gao, Lihong Liu, Jianmin Luo, L. Su, Zimin Sun, H. Tan, Hua-qing Wang, Jingwen Wang, Shuye Wang, Hongyu Zhang, Xiao-hong Zhang, Dao-bin Zhou, O. Bai, Gang Wu, Liling Zhang, Yizhuo Zhang   +57 more
semanticscholar   +1 more source

Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma

Clinical Epigenetics, 2020
Peripheral T-cell lymphoma (PTCL) is a rare and heterogeneous group of clinically aggressive diseases associated with poor prognosis. Except for ALK + anaplastic large-cell lymphoma (ALCL), most peripheral T-cell lymphomas are highly malignant and have ...
Ping Zhang, Mingzhi Zhang
semanticscholar   +1 more source

Follicular variant of peripheral T-cell lymphoma

Indian Journal of Pathology and Microbiology, 2017
Globally, peripheral T-cell lymphomas (PTCLs) constitute about 12% of all non-Hodgkin lymphomas, of which the unspecified category is the most common subtype (30%).
Archana Lakshmanan, S Annapurneswari, Sheila Nair   +2 more
doaj   +1 more source

Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.

Blood, 2019
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of mature T-cell malignancies with approximately one-third of cases designated as PTCL-not otherwise specified (PTCL-NOS).
Catalina Amador, T. Greiner, Tayla B. Heavican, Lynette M. Smith, Karen Galvis, Waseem G Lone, Alyssa Bouska, F. d'Amore, Martin Bjerregård Pedersen, S. Pileri, C. Agostinelli, A. Feldman, A. Rosenwald, G. Ott, A. Mottok, K. Savage, L. de Leval, P. Gaulard, S. Lim, C. Ong, S. Ondrejka, J. Song, E. Campo, E. Jaffe, L. Staudt, L. Rimsza, J. Vose, D. Weisenburger, W. Chan, J. Iqbal   +29 more
semanticscholar   +1 more source

The inducible T-cell co-stimulator molecule is expressed on subsets of T cells and is a new marker of lymphomas of T follicular helper cell-derivation

Haematologica, 2010
Background T follicular helper (TFH) cells reside in the light zone of germinal centers and are considered the cell of origin of angioimmunoblastic T-cell lymphoma.
Teresa Marafioti, Jennifer C. Paterson, Erica Ballabio, Andreas Chott, Yasodha Natkunam, Manuel Rodriguez-Justo, Anne Plonquet, Socorro M. Rodriguez-Pinilla, Wolfram Klapper, Martin-L. Hansmann, Stefano A. Pileri, Peter G. Isaacson, Harald Stein, Miguel A. Piris, David Y. Mason, Philippe Gaulard   +15 more
doaj   +1 more source

Lymphoma of the Uvula: Clinical, Morphological, Histopathological, and Genetic Characterization. A Nationwide Danish Study From 1980 to 2019

Frontiers in Surgery, 2021
Background: In the head and neck region the uvula is a rare site for extranodal lymphomas to develop. In this national study, we present six cases and provide an overview of the current literature, characterizing the clinical and histopathological ...
Lars Iversen, Lars Iversen, Patrick Rene Gerhard Eriksen, Simon Andreasen, Simon Andreasen, Erik Clasen-Linde, Preben Homøe, Irene Wessel, Christian von Buchwald, Steffen Heegaard, Steffen Heegaard   +10 more
doaj   +1 more source